Literature DB >> 10903328

Series introduction: the molecular and physiological basis of insulin resistance: emerging implications for metabolic and cardiovascular diseases.

A R Saltiel1.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10903328      PMCID： PMC314314          DOI： 10.1172/JCI10533

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  7 in total

1.  Plasma insulin concentrations in nondiabetic and early diabetic subjects. Determinations by a new sensitive immuno-assay technic.

Authors:  R S YALOW; S A BERSON
Journal:  Diabetes       Date:  1960 Jul-Aug       Impact factor: 9.461

2.  Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects.

Authors:  J Olefsky; J W Farquhar; G Reaven
Journal:  Diabetes       Date:  1973-07       Impact factor: 9.461

Review 3.  Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

Authors:  R A DeFronzo
Journal:  Diabetes       Date:  1988-06       Impact factor: 9.461

4.  The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man.

Authors:  C R Kahn; J S Flier; R S Bar; J A Archer; P Gorden; M M Martin; J Roth
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

Review 5.  Banting lecture 1988. Role of insulin resistance in human disease.

Authors:  G M Reaven
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

Review 6.  Role of insulin resistance in human disease (syndrome X): an expanded definition.

Authors:  G M Reaven
Journal:  Annu Rev Med       Date:  1993       Impact factor: 13.739

7.  Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.

Authors:  O G Kolterman; J Insel; M Saekow; J M Olefsky
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808
  7 in total
  17 in total

Review 1.  Regulation of adipocytokines and insulin resistance.

Authors:  M Fasshauer; R Paschke
Journal:  Diabetologia       Date:  2003-11-06       Impact factor: 10.122

Review 2.  Fatty acid binding proteins--the evolutionary crossroads of inflammatory and metabolic responses.

Authors:  Liza Makowski; Gökhan S Hotamisligil
Journal:  J Nutr       Date:  2004-09       Impact factor: 4.798

3.  Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome.

Authors:  Catherine M Phillips; Louisa Goumidi; Sandrine Bertrais; Martyn R Field; L Adrienne Cupples; Jose M Ordovas; Catherine Defoort; Julie A Lovegrove; Christian A Drevon; Michael J Gibney; Ellen E Blaak; Beata Kiec-Wilk; Britta Karlstrom; Jose Lopez-Miranda; Ross McManus; Serge Hercberg; Denis Lairon; Richard Planells; Helen M Roche
Journal:  J Lipid Res       Date:  2010-02-22       Impact factor: 5.922

4.  A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease.

Authors:  G Tuncman; E Erbay; X Hom; I De Vivo; H Campos; E B Rimm; G S Hotamisligil
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

5.  Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes.

Authors:  J Kawashima; K Tsuruzoe; H Motoshima; A Shirakami; K Sakai; Y Hirashima; T Toyonaga; E Araki
Journal:  Diabetologia       Date:  2003-02-11       Impact factor: 10.122

Review 6.  Insulin resistance syndrome in children : pathophysiology and potential management strategies.

Authors:  Tamás Decsi; Dénes Molnár
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

7.  Angiographic characteristics of the coronary artery in patients with type 2 diabetes.

Authors:  Tong-Guo Wu; Lexin Wang
Journal:  Exp Clin Cardiol       Date:  2002

8.  Diabetes treatment in 2025: can scientific advances keep pace with prevalence?

Authors:  Mansur Shomali
Journal:  Ther Adv Endocrinol Metab       Date:  2012-10       Impact factor: 3.565

9.  β-cell function is associated with metabolic syndrome in Mexican subjects.

Authors:  Blanca G Baez-Duarte; María Del Carmen Sánchez-Guillén; Ricardo Pérez-Fuentes; Irma Zamora-Ginez; Bertha Alicia Leon-Chavez; Cristina Revilla-Monsalve; Sergio Islas-Andrade
Journal:  Diabetes Metab Syndr Obes       Date:  2010-08-30       Impact factor: 3.168

Review 10.  Adipokines and hepatic insulin resistance.

Authors:  Yu Li; Lin Ding; Waseem Hassan; Daoud Abdelkader; Jing Shang
Journal:  J Diabetes Res       Date:  2013-05-16       Impact factor: 4.011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.